medroxyprogesterone acetate has been researched along with Invasiveness, Neoplasm in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.00) | 18.7374 |
| 1990's | 6 (24.00) | 18.2507 |
| 2000's | 9 (36.00) | 29.6817 |
| 2010's | 8 (32.00) | 24.3611 |
| 2020's | 1 (4.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, A; Kim, DY; Kim, JH; Kim, YM; Kim, YT; Lee, SW; Park, JY; Suh, DS | 1 |
| Allen, AM; Alorro, M; Chand, AL; Clyne, CD; Connelly, AA; Coulson, R; Deb, S; Ernst, M; George, AJ; Hannan, NJ; Harrison, CA; Kumar, B; Lazarus, KA; Liew, SH; Morrow, RJ; O'Toole, SA; Parslow, AC; Poh, A; Putoczki, T; Vargas, AC; Walton, KL; Yeap, EFW; Yee, NS | 1 |
| Blanco, MA; Bronson, RT; Chakrabarti, R; Chekmareva, M; Guo, F; Haffty, BG; Hua, Y; Kang, Y; Lu, X; Shen, M; Smith, HA; Wan, L; Wei, Y; Wu, H; Xing, Y; Yuan, M; Yuan, S | 1 |
| Li, Y; Sun, X; Wang, J; Wang, Y; Zhang, H | 1 |
| Ai, ZH; Dai, M; Ge, QL; Jiang, SH; Li, J; Liu, F; Teng, YC; Wang, YH; Wu, QK; Xu, QY; Yang, XM; Zhang, ZG; Zhu, XL | 1 |
| Baldacci, C; Flamini, MI; Fu, XD; Garibaldi, S; Genazzani, AR; Giretti, MS; Goglia, L; Sanchez, AM; Simoncini, T; Sitruk-Ware, R | 1 |
| Baldacci, C; Flamini, M; Fu, XD; Gadducci, A; Garibaldi, S; Genazzani, AR; Giretti, MS; Sanchez, AM; Simoncini, T | 1 |
| Langer, RD | 1 |
| Hanprasertpong, J; Manusirivithaya, S; Tangjitgamol, S | 1 |
| Branstetter, D; Dougall, WC; Erwert, R; Gonzalez-Suarez, E; Jacob, AP; Jones, J; Miller, R; Pinkas, J; Roudier-Meyer, MP | 1 |
| Anderson, GL; Aragaki, AK; Chlebowski, RT; Gass, M; Hendrix, SL; Johnson, KC; Kuller, LH; Lane, DS; Manson, JE; Ockene, J; Prentice, RL; Rajkovic, A; Ravdin, PM; Rohan, TE; Sarto, GE; Schenken, R; Stefanick, ML; Wactawski-Wende, J; Yasmeen, S | 1 |
| Chen, R; Hu, Q; Ji, L; Liao, QP; Wang, YL; Xie, Y; Yu, L; Zhang, Y | 1 |
| Chen, R; Hu, Q; Liao, Q; Xie, Y; Yu, L; Zhang, Y | 1 |
| Blok, LJ; Brinkmann, AO; Burger, CW; Chadha-Ajwani, S; de Ruiter, PE; Gielen, SC; Grootegoed, JA; Hanekamp, EE; Huikeshoven, FJ; Kühne, LC; Smid-Koopman, E | 1 |
| Blok, LJ; Burger, CW; Grootegoed, JA; Hanekamp, EE; Kühne, LM | 1 |
| Chen, XJ; Feng, YJ; Zhao, SJ | 1 |
| Anderson, GL; Chlebowski, RT; Hendrix, SL; Hubbell, FA; Jo O'Sullivan, M; Kooperberg, C; Kuller, LH; Lane, DS; Manson, JE; McTiernan, A; Pettinger, M; Prentice, RL; Rossouw, JE; Stefanick, ML | 1 |
| Fujimoto, J; Hori, M; Ichigo, S; Morishita, S; Tamaya, T | 2 |
| Isojima, S; Kawakita, M; Koyama, K; Nakata, Y; Ogasawara, T; Takemura, T; Tsuji, Y | 1 |
| Dgani, R; Fenig, E; Open, M; Shani, A; Vinker, S | 1 |
| Kunisue, H; Kurebayashi, J; Shimozuma, K; Sonoo, H; Tanaka, K; Udagawa, K; Yamamoto, S; Yamamoto, Y | 1 |
| Geyer, H; Kleine, W; Maier, T; Pfleiderer, A | 1 |
| Manart, FD; Montag, TW | 1 |
2 trial(s) available for medroxyprogesterone acetate and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women.
Topics: Aged; Breast Neoplasms; Drug Combinations; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Hormone Replacement Therapy; Humans; Incidence; Lymphatic Metastasis; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Postmenopause; Prognosis; United States | 2010 |
Depot-medroxyprogesterone acetate (DMPA) and risk of invasive squamous cell cervical cancer. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives.
Topics: Adult; Age Factors; Carcinoma, Squamous Cell; Case-Control Studies; Contraceptive Agents, Female; Delayed-Action Preparations; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Invasiveness; Risk; Risk Factors; Sexual Behavior; Smoking; Time Factors; Uterine Cervical Neoplasms | 1992 |
23 other study(ies) available for medroxyprogesterone acetate and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Continued medical treatment for persistent early endometrial cancer in young women.
Topics: Administration, Oral; Antineoplastic Agents, Hormonal; Biopsy; Carcinoma, Endometrioid; Disease-Free Survival; Drug Administration Schedule; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Female; Fertility Preservation; Follow-Up Studies; Humans; Intrauterine Devices; Levonorgestrel; Magnetic Resonance Imaging; Medroxyprogesterone Acetate; Megestrol Acetate; Myometrium; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Prognosis; Retrospective Studies; Time Factors; Treatment Failure; Treatment Outcome; Ultrasonography | 2021 |
The angiotensin receptor blocker, Losartan, inhibits mammary tumor development and progression to invasive carcinoma.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Angiotensin II Type 1 Receptor Blockers; Animals; Biopsy; Breast Neoplasms; Carcinogenesis; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Cell Proliferation; Disease Progression; Female; Humans; Immunohistochemistry; Interleukin-6; Losartan; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Mice; Neoplasm Invasiveness; Phosphorylation; Real-Time Polymerase Chain Reaction; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Signal Transduction; STAT3 Transcription Factor; Tumor Burden; Tumor Necrosis Factor-alpha; Up-Regulation | 2017 |
MTDH-SND1 interaction is crucial for expansion and activity of tumor-initiating cells in diverse oncogene- and carcinogen-induced mammary tumors.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Breast Neoplasms; Cell Adhesion Molecules; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Cell Transformation, Viral; Endonucleases; Female; Gene Expression Regulation, Neoplastic; Genetic Predisposition to Disease; HEK293 Cells; Humans; Mammary Glands, Animal; Mammary Tumor Virus, Mouse; Medroxyprogesterone Acetate; Membrane Proteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Neoplasm Invasiveness; Neoplastic Stem Cells; Nuclear Proteins; Phenotype; Protein Binding; RNA Interference; RNA-Binding Proteins; Time Factors; Transfection; Tumor Cells, Cultured | 2014 |
MPA influences tumor cell proliferation, migration, and invasion induced by RANKL through PRB involving the MAPK pathway in endometrial cancer.
Topics: Animals; Antineoplastic Agents, Hormonal; Cell Line, Tumor; Cell Movement; Cell Proliferation; Endometrial Hyperplasia; Female; Humans; MAP Kinase Signaling System; Medroxyprogesterone Acetate; Mice; Neoplasm Invasiveness; RANK Ligand; Receptors, Progesterone; Xenograft Model Antitumor Assays | 2015 |
Cholesterol Synthetase DHCR24 Induced by Insulin Aggravates Cancer Invasion and Progesterone Resistance in Endometrial Carcinoma.
Topics: Aged; Cell Line, Tumor; Cell Movement; Endometrial Neoplasms; Endometrium; Enzyme Induction; Female; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Insulin; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Invasiveness; Nerve Tissue Proteins; Oxidoreductases Acting on CH-CH Group Donors; Prognosis; Receptors, Progesterone; STAT3 Transcription Factor; Up-Regulation; Uterine Diseases | 2017 |
Comparative actions of progesterone, medroxyprogesterone acetate, drospirenone and nestorone on breast cancer cell migration and invasion.
Topics: Actins; Androstenes; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cytoskeleton; Estradiol; Humans; Medroxyprogesterone Acetate; Microfilament Proteins; Neoplasm Invasiveness; Norprogesterones; Progesterone; Signal Transduction | 2008 |
Extra-nuclear signaling of progesterone receptor to breast cancer cell movement and invasion through the actin cytoskeleton.
Topics: Actins; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cytoskeleton; Disease Progression; Humans; Medroxyprogesterone Acetate; Microfilament Proteins; Neoplasm Invasiveness; Progesterone; Receptors, Progesterone; rho-Associated Kinases; rhoA GTP-Binding Protein; Signal Transduction | 2008 |
Re: Estrogen plus progestin therapy and breast cancer in recently postmenopausal women.
Topics: Aged; Breast Neoplasms; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Invasiveness; Postmenopause; Randomized Controlled Trials as Topic; Risk; Time Factors | 2009 |
Fertility-sparing in endometrial cancer.
Topics: Adult; Algorithms; Biopsy; Cervix Uteri; Curettage; Endometrial Neoplasms; Female; Humans; Infertility, Female; Lymphatic Metastasis; MEDLINE; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Ploidies; Progesterone; Prognosis | 2009 |
RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Breast Neoplasms; Cell Proliferation; Cell Transformation, Neoplastic; Disease Models, Animal; Epithelial Cells; Female; Humans; Lung Neoplasms; Mammary Neoplasms, Experimental; Mammary Tumor Virus, Mouse; Medroxyprogesterone Acetate; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neoplasm Invasiveness; Precancerous Conditions; Progesterone; Progestins; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B | 2010 |
5-aza-2'-deoxycytidine improves the sensitivity of endometrial cancer cells to progesterone therapy.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Hormonal; Apoptosis; Azacitidine; Carcinoma; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Decitabine; Drug Synergism; Drug Therapy, Combination; Endometrial Neoplasms; Female; Humans; Medroxyprogesterone Acetate; Neoplasm Invasiveness; Receptors, Progesterone | 2012 |
Characterization of LHY-821, a novel moderately differentiated endometrial carcinoma cell line.
Topics: Animals; Cell Culture Techniques; Cell Line, Tumor; Endometrial Neoplasms; Female; Immunoblotting; Immunohistochemistry; Karyotyping; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Receptors, Progesterone; Transplantation, Heterologous | 2012 |
Consequences of loss of progesterone receptor expression in development of invasive endometrial cancer.
Topics: Adenocarcinoma; Cell Line, Tumor; Chondroitin Sulfate Proteoglycans; Endometrial Neoplasms; Female; Gene Expression Regulation, Neoplastic; Humans; Hyaluronan Receptors; Lectins, C-Type; Medroxyprogesterone Acetate; Neoplasm Invasiveness; Neoplasm Proteins; Receptors, Progesterone; Tenascin; Versicans | 2003 |
Progesterone receptor A and B expression and progestagen treatment in growth and spread of endometrial cancer cells in nude mice.
Topics: Animals; Cell Line; Endometrial Neoplasms; Female; Gene Expression Regulation, Neoplastic; Medroxyprogesterone Acetate; Mice; Mice, Nude; Neoplasm Invasiveness; Progestins; Receptors, Progesterone; Tumor Burden | 2004 |
[Influence of long-term treatment with MPA on the biological character of endometrial carcinoma Ishikawa cell].
Topics: Antineoplastic Agents, Hormonal; Cell Cycle; Drug Resistance, Neoplasm; Endometrial Neoplasms; Endometrium; Female; Gene Expression; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Medroxyprogesterone Acetate; Neoplasm Invasiveness; Receptors, Progesterone; Tumor Cells, Cultured | 2007 |
Estrogen plus progestin therapy and breast cancer in recently postmenopausal women.
Topics: Aged; Breast Neoplasms; Cohort Studies; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Invasiveness; Observation; Postmenopause; Proportional Hazards Models; Randomized Controlled Trials as Topic; Risk; Time Factors | 2008 |
Estrogen activates migration potential of endometrial cancer cells through basement membrane.
Topics: Antineoplastic Agents, Hormonal; Basement Membrane; Cell Movement; Danazol; Endometrial Neoplasms; Estradiol; Estrogen Antagonists; Female; Humans; Medroxyprogesterone Acetate; Neoplasm Invasiveness; Ovarian Neoplasms; Progesterone; Receptors, Estrogen; Tamoxifen; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 1996 |
Progesterone treatment decreases sulfate carbohydrate antigen on endometrial carcinoma cells and inhibits the cell binding to laminin.
Topics: Adenocarcinoma; Animals; Antibodies, Monoclonal; Antigens, Tumor-Associated, Carbohydrate; Carbohydrate Sequence; Endometrial Neoplasms; Epitopes; Female; Humans; Immunohistochemistry; Laminin; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Molecular Sequence Data; Neoplasm Invasiveness; Neoplasm Metastasis; Sulfates; Tumor Cells, Cultured | 1995 |
Estrogen activates invasiveness of endometrial cancel cells to the interstitium.
Topics: Cell Movement; Collagen; Dose-Response Relationship, Drug; Endometrial Neoplasms; Estradiol; Estrogen Antagonists; Female; Humans; Immunohistochemistry; Medroxyprogesterone Acetate; Neoplasm Invasiveness; Receptors, Estrogen; Tumor Cells, Cultured | 1995 |
Conservative treatment of adenocarcinoma of the endometrium in young patients. Is it appropriate?
Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Hormonal; Endometrial Neoplasms; Fallopian Tubes; Female; Humans; Hysterectomy; Medroxyprogesterone Acetate; Neoplasm Invasiveness; Ovariectomy; Parity; Polycystic Ovary Syndrome; Radiotherapy, Adjuvant | 1999 |
[A case of advanced breast cancer associated with humoral hypercalcemia that responded to medroxyprogesterone acetate and docetaxel].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Docetaxel; Drug Administration Schedule; Female; Humans; Hypercalcemia; Lymph Nodes; Lymphatic Metastasis; Medroxyprogesterone Acetate; Neoplasm Invasiveness; Paclitaxel; Taxoids | 2000 |
Estrogen and progesterone receptors in endometrial cancer and their prognostic relevance.
Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoma, Papillary; Carcinoma, Squamous Cell; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Multivariate Analysis; Neoplasm Invasiveness; Receptors, Estrogen; Receptors, Progesterone; Sarcoma; Survival Analysis; Uterine Neoplasms | 1990 |
Endolymphatic stromal myosis: surgical and hormonal therapy for extensive venous recurrence.
Topics: Adult; Antineoplastic Agents; Combined Modality Therapy; Delayed-Action Preparations; Estrogens, Conjugated (USP); Female; Hormones; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplastic Cells, Circulating; Pelvic Neoplasms; Receptors, Estrogen; Receptors, Progesterone; Renal Veins; Sarcoma; Uterine Neoplasms; Vena Cava, Inferior | 1989 |